Clinical Trial Update: Efficacy of Seventh Generation Bonding Agents as Short-Term Desensitizers Among Patients With Hypersensitivity [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating seventh-generation bonding agents as short-term desensitizers for dentin hypersensitivity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dentin Hypersensitivity

Drugs mentioned

• Seventh Generation Bonding Agents

Snippet

Sponsor: Dow University of Health Sciences | Conditions: Dentin Hypersensitivity | Phase 3 | Status: COMPLETED